Loading company…
Czech provider of pharmaceutical analysis, R&D and clinical testing services for regulatory compliance.
Quinta-Analytica provides pharmaceutical analysis, R&D and clinical testing to drug makers, biotech firms and regulators in Europe, the US and Asia. Founded in 1997 and operating mainly in the Czech Republic, its in-house clinical units have run over 300 bioequivalence, pharmacokinetic and bridging studies since 2007. LVA GmbH acquired a majority stake in November 2021, and the company reported revenue of USD 16.56 mn and EBITDA of USD 2.91 mn in 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in